A reduced lactose yogurt containing galactooligosaccharides (GOS) as a tool for lactose intolerant cover calcium daily intake that ensures bone health

Autores
Seijo, Mariana; Bonanno, Marina Soledad; Vénica, Claudia Inés; Pita Martín de Portela, María Luz; Bergamini, Carina Viviana; Wolf, Irma Veronica; Perotti, Maria Cristina; Zeni, Susana Noemi
Año de publicación
2019
Idioma
inglés
Tipo de recurso
documento de conferencia
Estado
versión publicada
Descripción
The galactooligosaccharides (GOS), natural prebiotics of human milk could be incorporated in dairy products, such as yogurt, by enzymatic action on milk lactose. We previously demonstrated: 1st. functional characteristics of such reduced-lactose yogurt containing GOS during the experimental normal growth; 2nd. Ca absorption (CaAbs) similar to that observed by feeding the recommended rodent diet. Objetive: To evaluate the beneficial effects of this reduced-lactose yogurt containing GOS in body composition and bone retention during normal growth. Male weaning Wistar rats (n=10 per group) received during 30 days AIN´93-G control diet (CD) or the yogurt containing GOS diet (ED). Food consumption was evaluated three times per week; body weight (BW) weekly; Ca and phosphorus (P) Abs during the last 3 days of the experience; femur Ca and P content, total skeleton bone mineral content (BMC) and bone mineral density (BMD) at the end of the study. Body composition and BMD of lumbar spine (LS), total (TT) and proximal (PrT) tibia BMD, and TT BMC were also evaluated. Result (mean±SD; Food consumption; BW; body fat and lean tissue percentages were similar in both groups. BMC (1.29±0.14 vs. 1.32±0.24 g), BMD (0.320±0.010 vs 0.320±0.005 g/cm2), TT BMD (0.246±0.022 vs 0.246 ± 0.018 g/cm2) and BMC (0.029±0.004 vs. 0.030±0.014); LS BMD (0.250±0.017 vs. 0.251±0.019 g/cm2) and Ca and P content in femur showed no significant differences. CaAbs % (84.9±2.2 vs. 80.0± 5.4%; p=0.062) and PAbs% (86.6±6.6 vs 78.0±7.1%; p<0.05); PrT BMD (0.303±0.056 g/cm2 vs. 0.266±0.018; p<0.05) were higher in ED vs. CD. The results evidenced similar body composition, higher Ca and P Abs and similar bone mass and retention. Conclusion: These results may suggest that the reduced lactose milk functional product assayed here appears to an optimal tool for maintaining an adequate intake of Ca, which prevents secondary bone disease caused by a milk-restricted diet
Fil: Seijo, Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina
Fil: Bonanno, Marina Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina
Fil: Vénica, Claudia Inés. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; Argentina
Fil: Pita Martín de Portela, María Luz. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina
Fil: Bergamini, Carina Viviana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; Argentina
Fil: Wolf, Irma Veronica. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; Argentina
Fil: Perotti, Maria Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; Argentina
Fil: Zeni, Susana Noemi. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina
46th Annual Meeting of the European Calcified Tissue Society
Budapest
Hungría
European Calcified Tissue Society
Materia
LACTOSE INTOLERANCE
GOS
CALCIUM
BONE HEALTH
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/184780
Acceder
id CONICETDig_3af6449356ee675d537bfe6ad289ea8c
oai_identifier_str oai:ri.conicet.gov.ar:11336/184780
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling A reduced lactose yogurt containing galactooligosaccharides (GOS) as a tool for lactose intolerant cover calcium daily intake that ensures bone healthSeijo, MarianaBonanno, Marina SoledadVénica, Claudia InésPita Martín de Portela, María LuzBergamini, Carina VivianaWolf, Irma VeronicaPerotti, Maria CristinaZeni, Susana NoemiLACTOSE INTOLERANCEGOSCALCIUMBONE HEALTHhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3The galactooligosaccharides (GOS), natural prebiotics of human milk could be incorporated in dairy products, such as yogurt, by enzymatic action on milk lactose. We previously demonstrated: 1st. functional characteristics of such reduced-lactose yogurt containing GOS during the experimental normal growth; 2nd. Ca absorption (CaAbs) similar to that observed by feeding the recommended rodent diet. Objetive: To evaluate the beneficial effects of this reduced-lactose yogurt containing GOS in body composition and bone retention during normal growth. Male weaning Wistar rats (n=10 per group) received during 30 days AIN´93-G control diet (CD) or the yogurt containing GOS diet (ED). Food consumption was evaluated three times per week; body weight (BW) weekly; Ca and phosphorus (P) Abs during the last 3 days of the experience; femur Ca and P content, total skeleton bone mineral content (BMC) and bone mineral density (BMD) at the end of the study. Body composition and BMD of lumbar spine (LS), total (TT) and proximal (PrT) tibia BMD, and TT BMC were also evaluated. Result (mean±SD; Food consumption; BW; body fat and lean tissue percentages were similar in both groups. BMC (1.29±0.14 vs. 1.32±0.24 g), BMD (0.320±0.010 vs 0.320±0.005 g/cm2), TT BMD (0.246±0.022 vs 0.246 ± 0.018 g/cm2) and BMC (0.029±0.004 vs. 0.030±0.014); LS BMD (0.250±0.017 vs. 0.251±0.019 g/cm2) and Ca and P content in femur showed no significant differences. CaAbs % (84.9±2.2 vs. 80.0± 5.4%; p=0.062) and PAbs% (86.6±6.6 vs 78.0±7.1%; p<0.05); PrT BMD (0.303±0.056 g/cm2 vs. 0.266±0.018; p<0.05) were higher in ED vs. CD. The results evidenced similar body composition, higher Ca and P Abs and similar bone mass and retention. Conclusion: These results may suggest that the reduced lactose milk functional product assayed here appears to an optimal tool for maintaining an adequate intake of Ca, which prevents secondary bone disease caused by a milk-restricted dietFil: Seijo, Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; ArgentinaFil: Bonanno, Marina Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; ArgentinaFil: Vénica, Claudia Inés. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; ArgentinaFil: Pita Martín de Portela, María Luz. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; ArgentinaFil: Bergamini, Carina Viviana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; ArgentinaFil: Wolf, Irma Veronica. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; ArgentinaFil: Perotti, Maria Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; ArgentinaFil: Zeni, Susana Noemi. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina46th Annual Meeting of the European Calcified Tissue SocietyBudapestHungríaEuropean Calcified Tissue SocietySpringer2019info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónJournalhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttp://hdl.handle.net/11336/184780A reduced lactose yogurt containing galactooligosaccharides (GOS) as a tool for lactose intolerant cover calcium daily intake that ensures bone health; 46th Annual Meeting of the European Calcified Tissue Society; Budapest; Hungría; 2019; 151-1511432-0827CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007/s00223-019-00541-0Internacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-11-05T10:31:57Zoai:ri.conicet.gov.ar:11336/184780instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-11-05 10:31:57.51CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv A reduced lactose yogurt containing galactooligosaccharides (GOS) as a tool for lactose intolerant cover calcium daily intake that ensures bone health
title A reduced lactose yogurt containing galactooligosaccharides (GOS) as a tool for lactose intolerant cover calcium daily intake that ensures bone health
spellingShingle A reduced lactose yogurt containing galactooligosaccharides (GOS) as a tool for lactose intolerant cover calcium daily intake that ensures bone health
Seijo, Mariana
LACTOSE INTOLERANCE
GOS
CALCIUM
BONE HEALTH
title_short A reduced lactose yogurt containing galactooligosaccharides (GOS) as a tool for lactose intolerant cover calcium daily intake that ensures bone health
title_full A reduced lactose yogurt containing galactooligosaccharides (GOS) as a tool for lactose intolerant cover calcium daily intake that ensures bone health
title_fullStr A reduced lactose yogurt containing galactooligosaccharides (GOS) as a tool for lactose intolerant cover calcium daily intake that ensures bone health
title_full_unstemmed A reduced lactose yogurt containing galactooligosaccharides (GOS) as a tool for lactose intolerant cover calcium daily intake that ensures bone health
title_sort A reduced lactose yogurt containing galactooligosaccharides (GOS) as a tool for lactose intolerant cover calcium daily intake that ensures bone health
dc.creator.none.fl_str_mv Seijo, Mariana
Bonanno, Marina Soledad
Vénica, Claudia Inés
Pita Martín de Portela, María Luz
Bergamini, Carina Viviana
Wolf, Irma Veronica
Perotti, Maria Cristina
Zeni, Susana Noemi
author Seijo, Mariana
author_facet Seijo, Mariana
Bonanno, Marina Soledad
Vénica, Claudia Inés
Pita Martín de Portela, María Luz
Bergamini, Carina Viviana
Wolf, Irma Veronica
Perotti, Maria Cristina
Zeni, Susana Noemi
author_role author
author2 Bonanno, Marina Soledad
Vénica, Claudia Inés
Pita Martín de Portela, María Luz
Bergamini, Carina Viviana
Wolf, Irma Veronica
Perotti, Maria Cristina
Zeni, Susana Noemi
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv LACTOSE INTOLERANCE
GOS
CALCIUM
BONE HEALTH
topic LACTOSE INTOLERANCE
GOS
CALCIUM
BONE HEALTH
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv The galactooligosaccharides (GOS), natural prebiotics of human milk could be incorporated in dairy products, such as yogurt, by enzymatic action on milk lactose. We previously demonstrated: 1st. functional characteristics of such reduced-lactose yogurt containing GOS during the experimental normal growth; 2nd. Ca absorption (CaAbs) similar to that observed by feeding the recommended rodent diet. Objetive: To evaluate the beneficial effects of this reduced-lactose yogurt containing GOS in body composition and bone retention during normal growth. Male weaning Wistar rats (n=10 per group) received during 30 days AIN´93-G control diet (CD) or the yogurt containing GOS diet (ED). Food consumption was evaluated three times per week; body weight (BW) weekly; Ca and phosphorus (P) Abs during the last 3 days of the experience; femur Ca and P content, total skeleton bone mineral content (BMC) and bone mineral density (BMD) at the end of the study. Body composition and BMD of lumbar spine (LS), total (TT) and proximal (PrT) tibia BMD, and TT BMC were also evaluated. Result (mean±SD; Food consumption; BW; body fat and lean tissue percentages were similar in both groups. BMC (1.29±0.14 vs. 1.32±0.24 g), BMD (0.320±0.010 vs 0.320±0.005 g/cm2), TT BMD (0.246±0.022 vs 0.246 ± 0.018 g/cm2) and BMC (0.029±0.004 vs. 0.030±0.014); LS BMD (0.250±0.017 vs. 0.251±0.019 g/cm2) and Ca and P content in femur showed no significant differences. CaAbs % (84.9±2.2 vs. 80.0± 5.4%; p=0.062) and PAbs% (86.6±6.6 vs 78.0±7.1%; p<0.05); PrT BMD (0.303±0.056 g/cm2 vs. 0.266±0.018; p<0.05) were higher in ED vs. CD. The results evidenced similar body composition, higher Ca and P Abs and similar bone mass and retention. Conclusion: These results may suggest that the reduced lactose milk functional product assayed here appears to an optimal tool for maintaining an adequate intake of Ca, which prevents secondary bone disease caused by a milk-restricted diet
Fil: Seijo, Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina
Fil: Bonanno, Marina Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina
Fil: Vénica, Claudia Inés. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; Argentina
Fil: Pita Martín de Portela, María Luz. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina
Fil: Bergamini, Carina Viviana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; Argentina
Fil: Wolf, Irma Veronica. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; Argentina
Fil: Perotti, Maria Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; Argentina
Fil: Zeni, Susana Noemi. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina
46th Annual Meeting of the European Calcified Tissue Society
Budapest
Hungría
European Calcified Tissue Society
description The galactooligosaccharides (GOS), natural prebiotics of human milk could be incorporated in dairy products, such as yogurt, by enzymatic action on milk lactose. We previously demonstrated: 1st. functional characteristics of such reduced-lactose yogurt containing GOS during the experimental normal growth; 2nd. Ca absorption (CaAbs) similar to that observed by feeding the recommended rodent diet. Objetive: To evaluate the beneficial effects of this reduced-lactose yogurt containing GOS in body composition and bone retention during normal growth. Male weaning Wistar rats (n=10 per group) received during 30 days AIN´93-G control diet (CD) or the yogurt containing GOS diet (ED). Food consumption was evaluated three times per week; body weight (BW) weekly; Ca and phosphorus (P) Abs during the last 3 days of the experience; femur Ca and P content, total skeleton bone mineral content (BMC) and bone mineral density (BMD) at the end of the study. Body composition and BMD of lumbar spine (LS), total (TT) and proximal (PrT) tibia BMD, and TT BMC were also evaluated. Result (mean±SD; Food consumption; BW; body fat and lean tissue percentages were similar in both groups. BMC (1.29±0.14 vs. 1.32±0.24 g), BMD (0.320±0.010 vs 0.320±0.005 g/cm2), TT BMD (0.246±0.022 vs 0.246 ± 0.018 g/cm2) and BMC (0.029±0.004 vs. 0.030±0.014); LS BMD (0.250±0.017 vs. 0.251±0.019 g/cm2) and Ca and P content in femur showed no significant differences. CaAbs % (84.9±2.2 vs. 80.0± 5.4%; p=0.062) and PAbs% (86.6±6.6 vs 78.0±7.1%; p<0.05); PrT BMD (0.303±0.056 g/cm2 vs. 0.266±0.018; p<0.05) were higher in ED vs. CD. The results evidenced similar body composition, higher Ca and P Abs and similar bone mass and retention. Conclusion: These results may suggest that the reduced lactose milk functional product assayed here appears to an optimal tool for maintaining an adequate intake of Ca, which prevents secondary bone disease caused by a milk-restricted diet
publishDate 2019
dc.date.none.fl_str_mv 2019
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/conferenceObject
Reunión
Journal
http://purl.org/coar/resource_type/c_5794
info:ar-repo/semantics/documentoDeConferencia
status_str publishedVersion
format conferenceObject
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/184780
A reduced lactose yogurt containing galactooligosaccharides (GOS) as a tool for lactose intolerant cover calcium daily intake that ensures bone health; 46th Annual Meeting of the European Calcified Tissue Society; Budapest; Hungría; 2019; 151-151
1432-0827
CONICET Digital
CONICET
url http://hdl.handle.net/11336/184780
identifier_str_mv A reduced lactose yogurt containing galactooligosaccharides (GOS) as a tool for lactose intolerant cover calcium daily intake that ensures bone health; 46th Annual Meeting of the European Calcified Tissue Society; Budapest; Hungría; 2019; 151-151
1432-0827
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007/s00223-019-00541-0
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/pdf
dc.coverage.none.fl_str_mv Internacional
dc.publisher.none.fl_str_mv Springer
publisher.none.fl_str_mv Springer
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1847977998866710528
score 13.084122

Publicaciones similares